Table 5: Intramural historical comparisons of observed 5-year survival rates by cancer types for consecutive time periods.
|
CANCER |
1989-1995 |
1996-2003 |
1989-1995 Med Surv Mos |
1996-2003 Med Surv Mos |
1989-1995 5-yr surv % |
1996-2003 5-yr surv % |
P val KM |
|
BREAST |
1375 |
2391 |
NR |
NR |
82 |
86 |
.002 |
|
GYNECOLOGIC |
|
|
|
|
|
|
|
|
Cervix |
186 |
157 |
NR |
NR |
72 |
70 |
.753 |
|
Uterus |
212 |
411 |
NR |
NR |
73 |
77 |
.147 |
|
Ovary(no borderline) |
213 |
279 |
37 |
45 |
40 |
45 |
.180 |
|
GASTROINTESTINAL |
|
|
|
|
|
|
|
|
Colon |
479 |
797 |
64 |
80 |
51 |
56 |
.142 |
|
Rectal-RS |
175 |
350 |
93 |
105 |
63 |
66 |
.472 |
|
Esophagus |
71 |
97 |
5 |
11 |
14 |
17 |
.413 |
|
Liver & other biliary |
44 |
120 |
5 |
7 |
5 |
15 |
.0008 |
|
Pancreas |
176 |
263 |
6 |
8 |
3 |
6 |
.664 |
|
Stomach |
84 |
149 |
13 |
16 |
14 |
19 |
.289 |
|
UROLOGIC |
|
|
|
|
|
|
|
|
Prostate |
1114 |
1915 |
NR |
NR |
80 |
88 |
<.0001 |
|
Bladder w/ in situ |
292 |
487 |
NR |
109 |
74 |
68 |
.683 |
|
Kidney & Renal Pelvis |
140 |
251 |
72 |
90 |
51 |
55 |
.408 |
|
Testis |
83 |
89 |
NR |
NR |
95 |
97 |
.545 |
|
HEAD & NECK |
|
|
|
|
|
|
|
|
Larynx |
61 |
68 |
NR |
105 |
66 |
62 |
.593 |
|
Oral, Pharynx |
147 |
226 |
76 |
99 |
55 |
60 |
.393 |
|
Thyroid |
85 |
309 |
NR |
NR |
95 |
95 |
.928 |
|
|
|
|
|
|
|
|
|
|
LUNG |
1082 |
1627 |
12 |
14 |
18 |
24 |
.004 |
|
MELANOMA of skin |
313 |
595 |
NR |
NR |
78 |
80 |
.449 |
|
BRAIN |
82 |
255 |
15 |
15 |
28 |
23 |
.642 |
|
HEMATOLOGIC |
|
|
|
|
|
|
|
|
Leukemia |
164 |
329 |
15 |
27 |
30 |
41 |
.015 |
|
Lymphoma-NHL |
319 |
480 |
50 |
107 |
46 |
59 |
.0003 |
|
Myeloma |
65 |
116 |
30 |
45 |
28 |
36 |
.116 |
|
Hodgkin’s |
63 |
80 |
NR |
NR |
85 |
85 |
.928 |
|
ALL Invasive |
7,662 |
12,977 |
87 |
120 |
56 |
62 |
<.0001 |
NR=not reached.